Mezzion Pharma Co. Ltd
Clinical trials sponsored by Mezzion Pharma Co. Ltd, explained in plain language.
-
Heart drug udenafil tested for long-term safety in teens with rare heart defect
Disease control CompletedThis study looked at the long-term safety of udenafil in 301 adolescents with single ventricle heart disease who had Fontan surgery. Participants took the drug for 52 weeks. The main goal was to track side effects, with secondary measures including exercise capacity and blood ves…
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Heart drug shows promise for liver health in kids with rare heart condition
Disease control CompletedThis study tested whether the drug udenafil can reduce liver stiffness in 88 children with single ventricle heart disease, a condition where the heart has only one pumping chamber. Participants took udenafil twice daily for 52 weeks, and liver stiffness was measured using ultraso…
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC